- Home
- ESQ vs SGP Comparison
ESQ vs SGP Comparison
Compare ESQ & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESQ | SGP |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 891.1M |
| IPO Year | 2017 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ESQ | SGP |
|---|---|---|
| Price | $114.12 | $26.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $120.33 | $45.00 |
| AVG Volume (30 Days) | ★ 117.1K | 62.5K |
| Earning Date | 04-23-2026 | 05-15-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ 14.20 | N/A |
| EPS | ★ 2.89 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.15 | N/A |
| Revenue Next Year | $39.09 | N/A |
| P/E Ratio | $38.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $92.33 | $17.06 |
| 52 Week High | $134.65 | $30.56 |
Technical Indicators
Market Signals| Indicator | ESQ | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 37.21 | 69.13 |
| Support Level | $103.79 | $24.87 |
| Resistance Level | $118.48 | $27.53 |
| Average True Range (ATR) | 3.65 | 1.17 |
| MACD | -1.90 | 0.01 |
| Stochastic Oscillator | 13.45 | 86.16 |
Price Performance
Historical ComparisonAbout ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.